The Case of Combined Empty Sella Syndrome and Adrenal Tumor with Pseudo Precocious Puberty in 4 Years Old Boy
Journal Title: Міжнародний ендокринологічний журнал - Year 2015, Vol 5, Issue 69
Abstract
It is described a case of combined empty sella syndrome and adrenal tumor with pseudo precocious puberty in 4 years old boy. Before the operative treatment of adrenal tumor pseudo precocious puberty was determined, then after surgery hypogonadotropic hypogonadism and short stature on the background of empty sella syndrome were diagnozed. The treatment with gene engineering growth hormone (the patient had open physis) and course of chorionic gonadotropin are required.
Authors and Affiliations
Sh. A. Babakhodjaieva, Yu. M. Urmanova
Keywords
Related Articles
- EP ID EP219687
- DOI -
- Views 60
- Downloads 0
Coagulating Activity of Plasma Factors and Ways of their Correction by means of Electromagnetic Radiation of Extremely High Frequency in Patients with Diabetes Mellitus
No abstract
Using ultra-rapid insulin analogs in children and adolescents with type 1 diabetes mellitus
Background. The purpose of the study was a retrospective comparative analysis of using insulin analogues of the prolonged and ultra-short action and human genetically engineered insulins of middle and short action in chi...
Impact of Gender and Age Factors on the Correlation of Pituitary-Thyroid Hormones in Patients with Autoimmune Thyroiditis
In 292 patients with autoimmune thyroiditis, indicators of thyroid homeostasis were studied by levels of thyroid stimulating hormone (TSH), T3, T4, FT4, as well as their ratio in groups of men and women under the age of...
Effect of Metformin on the Medullary Thyroid Cancer Cells
Background. Medullary thyroid cancer (MTC) is associated with activation of mTOR signaling pathways. Recent studies showed that the anti-diabetic agent metformin decreases proliferation of cancer cells through AMPK-depen...
New Opportunities for Diabetes Mellitus Treatment
The paper presents the results of the study of the efficiency and safety of the insulins Insuman® Rapid, Insuman® Basal, Insuman® Comb 25 in patients with type 2 diabetes mellitus. Those medications were found to have hi...